Vancouver, British Columbia--(Newsfile Corp. - November 24, 2023) - DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to announce that it has entered into a non-binding letter of intent dated November 22, 2023 (the "LOI") with V.V.T. Med Ltd. ("VVT"), an Israeli corporation, and Exiteam Acquisition Corp. ("EAC"), a British Columbia corporation, pursuant to which DXI has agreed to acquire all of the issued and outstanding shares in the capital of VVT (the "VVT Shares") and EAC (the "EAC Shares"), as well as all other issued securities of VVT and EAC, upon the terms and conditions set out in a definitive agreement to be entered into by the parties (the "Proposed Transaction"). The Proposed Transaction is expected to enable DXI to meet the initial listing requirements of the TSX Venture Exchange (the "TSXV" or the "Exchange") for the reactivation of DXI. Following the completion of the Proposed Transaction, DXI (the "Resulting Issuer") will continue the business of VVT, being a new medical treatment for varicose veins and will be listed on the TSXV under the life sciences sector. All currency figures quoted herein are in Canadian dollars unless stated otherwise.

VANCOUVER, BC, Nov. 23, 2023 /CNW/ - The following issues have been halted by CIRO